Lactobacillus plantarum

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Lactobacillus plantarum
DrugBank Accession Number
DB11360
Background

Lactobacillus plantarum is a member of Lactobacillus, or lactic acid bacteria, that it is widely used in the food industry as a microbial starter and probiotic microorganism. It is considered to be one of versatile species that carry out fermentative and metabolic processes, while exhibiting an antagonistic activity against pathogenic and spoilage microorganisms. L. plantarum produces different antimicrobial agents such as organic acids, hydrogen peroxide, diacetyl, bacteriocins, and antimicrobial peptides 1.

Type
Biotech
Groups
Investigational
Synonyms
  • Lactobacillus arabinosus whole
  • Lactobacillus arizonensis whole
  • Lactobacillus plantarum whole

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
AldicomLiquid30 g/100gOralNAME2019-10-09Not applicableUS flag
CarecnePowder51.9 g/100gOralBiorhythm Co., Ltd2018-05-23Not applicableUS flag
Jangdaewon Probiotics KidsPowder30 mg/2gOralDaewon Pharmaceutical Co., Ltd.2019-02-01Not applicableUS flag
Kimchi Lactic Acid 1000Granule0.101 g/1.5gOralBiogenicskorea Co., Ltd.2015-10-14Not applicableUS flag
Kimchi Lactobacillus 1000Granule0.04 g/1.5gOralBiogenicskorea Co., Ltd.2015-11-11Not applicableUS flag
Kimchi Lactobacillus 2000Granule0.08 g/1.5gOralBiogenicskorea Co., Ltd.2015-11-11Not applicableUS flag
Kimchi Lactobacillus 5000Granule0.19 g/1.5gOralBiogenicskorea Co., Ltd.2020-02-01Not applicableUS flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
BİOBER-ZN ORAL SÜSPANSİYON İÇEREN FLAKON, 5 ADETLactobacillus plantarum (14.2 mg/10ml) + Bifidobacterium longum infantis (10 mg/10ml) + MRx-4DP0004 (6.6 mg/10ml) + Zinc sulfate heptahydrate (15 mg/10ml)SuspensionOralBERKO İLAÇ VE KİMYA SAN. A.Ş.2020-08-14Not applicableTurkey flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
AldicomLactobacillus plantarum (30 g/100g)LiquidOralNAME2019-10-09Not applicableUS flag
CarecneLactobacillus plantarum (51.9 g/100g)PowderOralBiorhythm Co., Ltd2018-05-23Not applicableUS flag
Jangdaewon Probiotics KidsLactobacillus plantarum (30 mg/2g)PowderOralDaewon Pharmaceutical Co., Ltd.2019-02-01Not applicableUS flag
Kimchi Lactic Acid 1000Lactobacillus plantarum (0.101 g/1.5g)GranuleOralBiogenicskorea Co., Ltd.2015-10-14Not applicableUS flag
Kimchi Lactobacillus 1000Lactobacillus plantarum (0.04 g/1.5g)GranuleOralBiogenicskorea Co., Ltd.2015-11-11Not applicableUS flag
Kimchi Lactobacillus 2000Lactobacillus plantarum (0.08 g/1.5g)GranuleOralBiogenicskorea Co., Ltd.2015-11-11Not applicableUS flag
Kimchi Lactobacillus 5000Lactobacillus plantarum (0.19 g/1.5g)GranuleOralBiogenicskorea Co., Ltd.2020-02-01Not applicableUS flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
QFC21096ON
CAS number
Not Available

References

General References
  1. Lobos O, Barrera A, Padilla C: Microorganisms of the Intestinal Microbiota of Oncorhynchus Mykiss Produce Antagonistic Substances Against Bacteria Contaminating Food and Causing Disease in Humans. Ital J Food Saf. 2017 Jun 27;6(2):6240. doi: 10.4081/ijfs.2017.6240. eCollection 2017 Apr 13. [Article]
PubChem Substance
347911199
RxNav
1673942
Wikipedia
Lactobacillus_plantarum

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedTreatmentIrritable Bowel Syndrome (IBS)1
3RecruitingPreventionAntibiotic Side Effect / Implant Capsular Contracture / Implant Complication / Implant Expulsion / Implant Infection / Implant site infection / Implant Site Pocket Infection1
3RecruitingPreventionHematopoietic and Lymphoid System Neoplasm / Leukemias / Malignant Lymphomas / Plasma Cell Myeloma1
2CompletedTreatmentAnxiety Disorders / Depression1
2, 3CompletedPreventionDiarrhea1
2, 3CompletedTreatmentConstipation - Functional2
1CompletedSupportive CareHematopoietic Organs; Disorder1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
LiquidOral30 g/100g
CapsuleOral
CapsuleVaginal
DoucheVaginal
SuspensionOral
PowderOral51.9 g/100g
PowderOral30 mg/2g
GranuleOral0.101 g/1.5g
GranuleOral0.04 g/1.5g
GranuleOral0.08 g/1.5g
GranuleOral0.19 g/1.5g
Capsule; insertVaginal
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on December 03, 2015 16:52 / Updated on February 13, 2021 10:52